{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T01:05:25Z","timestamp":1790298325579,"version":"4.1.0"},"reference-count":59,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Giant cell arteritis (GCA) is the most common form of vasculitis affecting patients above the age of 50. Over the past few decades, our understanding of the pathophysiology, clinical presentation, and treatment of the disease has increased tremendously. We now recognize that there is more than just the compromise of the temporal artery and its branches. Advances in technology and immunology have led to new diagnostic imaging methods and more targeted treatments with fewer side effects. The aim of this review is to summarize the advances in the presentation, diagnosis, and treatment of GCA.<\/jats:p>","DOI":"10.4103\/tjo.tjo-d-26-00039","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T16:01:06Z","timestamp":1790179266000},"page":"397-405","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Diagnosis and management of giant cell arteritis"],"prefix":"10.4103","volume":"16","author":[{"given":"Laura","family":"Bonelli","sequence":"first","affiliation":[{"name":"Stein Eye Institute, David Geffen School of Medicine, University of California, Los Angeles, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony C.","family":"Arnold","sequence":"additional","affiliation":[{"name":"Stein Eye Institute, David Geffen School of Medicine, University of California, Los Angeles, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,9,23]]},"reference":[{"key":"R1-20260924","doi-asserted-by":"crossref","first-page":"192","DOI":"10.7326\/0003-4819-123-3-199508010-00006","article-title":"The incidence of giant cell arteritis in Olmsted County, Minnesota: Apparent fluctuations in a cyclic pattern","volume":"123","author":"Salvarani","year":"1995","journal-title":"Ann Intern Med"},{"key":"R2-20260924","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s13075-021-02450-w","article-title":"A meta-analysis of the epidemiology of giant cell arteritis across time and space","volume":"23","author":"Li","year":"2021","journal-title":"Arthritis Res Ther"},{"key":"R3-20260924","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1136\/bjo.2009.177220","article-title":"Giant cell arteritis in Asians: A comparative study","volume":"95","author":"Pereira","year":"2011","journal-title":"Br J Ophthalmol"},{"key":"R4-20260924","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/mr\/roac013","article-title":"Clinical profile and outcome of large-vessel giant cell arteritis in Japanese patients: A single-Centre retrospective cohort study","volume":"33","author":"Yamaguchi","year":"2023","journal-title":"Mod Rheumatol"},{"key":"R5-20260924","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/eye.2016.199","article-title":"Ophthalmic presentation of giant cell arteritis in African-Americans","volume":"31","author":"Garrity","year":"2017","journal-title":"Eye (Lond)"},{"key":"R6-20260924","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1177\/10815589231152821","article-title":"The incidence and characteristics of giant cell arteritis in Hispanics and the associated outcomes of ischemic ocular events and stroke","volume":"71","author":"Smith","year":"2023","journal-title":"J Investig Med"},{"key":"R7-20260924","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1001\/jamaophthalmol.2019.2919","article-title":"Association of giant cell arteritis with race","volume":"137","author":"Gruener","year":"2019","journal-title":"JAMA Ophthalmol"},{"issue":"Suppl 124","key":"R8-20260924","first-page":"15","article-title":"Giant cell arteritis: More than a cranial disease","volume":"38","author":"Gonz\u00e1lez-Gay","year":"2020","journal-title":"Clin Exp Rheumatol"},{"key":"R9-20260924","doi-asserted-by":"crossref","first-page":"i32","DOI":"10.1093\/rheumatology\/kex424","article-title":"Large-vessel giant cell arteritis: Diagnosis, monitoring and management","volume":"57","author":"Koster","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"R10-20260924","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/1529-0131(199902)42:2<311::AID-ANR14>3.0.CO;2-F","article-title":"Disease pattern in cranial and large-vessel giant cell arteritis","volume":"42","author":"Brack","year":"1999","journal-title":"Arthritis Rheum"},{"key":"R11-20260924","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/art.1780330810","article-title":"The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis","volume":"33","author":"Hunder","year":"1990","journal-title":"Arthritis Rheum"},{"key":"R12-20260924","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/jama.287.1.92","article-title":"Does this patient have temporal arteritis?","volume":"287","author":"Smetana","year":"2002","journal-title":"JAMA"},{"key":"R13-20260924","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1001\/jamainternmed.2020.3050","article-title":"Diagnostic accuracy of symptoms, physical signs, and laboratory tests for giant cell arteritis: A systematic review and meta-analysis","volume":"180","author":"van der Geest","year":"2020","journal-title":"JAMA Intern Med"},{"key":"R14-20260924","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1093\/rheumatology\/35.11.1161","article-title":"A prospective study of 287 patients with polymyalgia rheumatica and temporal arteritis: Clinical and laboratory manifestations at onset of disease and at the time of diagnosis","volume":"35","author":"Myklebust","year":"1996","journal-title":"Br J Rheumatol"},{"key":"R15-20260924","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0039-6257(97)00052-0","article-title":"Current concepts in giant cell (temporal) arteritis","volume":"42","author":"Ghanchi","year":"1997","journal-title":"Surv Ophthalmol"},{"key":"R16-20260924","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0140-6736(12)60680-1","article-title":"Polymyalgia rheumatica","volume":"381","author":"Kermani","year":"2013","journal-title":"Lancet"},{"key":"R17-20260924","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1001\/jama.2016.5444","article-title":"Polymyalgia rheumatica and giant cell arteritis: A systematic review","volume":"315","author":"Buttgereit","year":"2016","journal-title":"JAMA"},{"key":"R18-20260924","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0002-9394(99)80193-7","article-title":"Occult giant cell arteritis: Ocular manifestations","volume":"125","author":"Hayreh","year":"1998","journal-title":"Am J Ophthalmol"},{"key":"R19-20260924","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0002-9394(99)80192-5","article-title":"Ocular manifestations of giant cell arteritis","volume":"125","author":"Hayreh","year":"1998","journal-title":"Am J Ophthalmol"},{"key":"R20-20260924","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1007\/s00417-016-3434-7","article-title":"Giant cell arteritis: Ophthalmic manifestations of a systemic disease","volume":"254","author":"De Smit","year":"2016","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R21-20260924","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1016\/j.ophtha.2016.05.008","article-title":"Evaluating the incidence of arteritic ischemic optic neuropathy and other causes of vision loss from giant cell arteritis","volume":"123","author":"Chen","year":"2016","journal-title":"Ophthalmology"},{"key":"R22-20260924","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1038\/s41433-023-02433-y","article-title":"Giant cell arteritis: Reviewing the advancing diagnostics and management","volume":"37","author":"Bilton","year":"2023","journal-title":"Eye (Lond)"},{"key":"R23-20260924","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S0002-9394(14)73080-6","article-title":"Fluorescein angiography in acute nonarteritic anterior ischemic optic neuropathy","volume":"117","author":"Arnold","year":"1994","journal-title":"Am J Ophthalmol"},{"key":"R24-20260924","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s40942-022-00422-z","article-title":"Choroidal ischemia as one cardinal sign in giant cell arteritis","volume":"8","author":"Casella","year":"2022","journal-title":"Int J Retina Vitreous"},{"key":"R25-20260924","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/01.md.0000180043.19285.54","article-title":"Giant cell arteritis: Laboratory tests at the time of diagnosis in a series of 240 patients","volume":"84","author":"Gonzalez-Gay","year":"2005","journal-title":"Medicine (Baltimore)"},{"key":"R26-20260924","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1136\/bmj.286.6361.266","article-title":"Simple rule for calculating normal erythrocyte sedimentation rate","volume":"286","author":"Miller","year":"1983","journal-title":"Br Med J (Clin Res Ed)"},{"key":"R27-20260924","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.ophtha.2010.10.002","article-title":"Giant cell arteritis: Laboratory predictors of a positive temporal artery biopsy","volume":"118","author":"Walvick","year":"2011","journal-title":"Ophthalmology"},{"key":"R28-20260924","first-page":"128","article-title":"Giant-cell arteritis with normal erythrocyte sedimentation rate: Case report and review of the literature","volume":"42","author":"Zweegman","year":"1993","journal-title":"Neth J Med"},{"key":"R29-20260924","first-page":"73","article-title":"Giant cell arteritis with an erythrocyte sedimentation rate lower than 50","volume":"19","author":"Mart\u00ednez-Taboada","year":"2000","journal-title":"Clin Rheumatol"},{"key":"R30-20260924","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0002-9394(14)70123-0","article-title":"Giant cell arteritis: Validity and reliability of various diagnostic criteria","volume":"123","author":"Hayreh","year":"1997","journal-title":"Am J Ophthalmol"},{"key":"R31-20260924","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.semarthrit.2011.10.005","article-title":"Utility of erythrocyte sedimentation rate and C-reactive protein for the diagnosis of giant cell arteritis","volume":"41","author":"Kermani","year":"2012","journal-title":"Semin Arthritis Rheum"},{"key":"R32-20260924","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0161-6420(02)01076-X","article-title":"Thrombocytosis in patients with biopsy-proven giant cell arteritis","volume":"109","author":"Foroozan","year":"2002","journal-title":"Ophthalmology"},{"key":"R33-20260924","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1177\/112067210401400310","article-title":"Role of thrombocytosis in diagnosis of giant cell arteritis and differentiation of arteritic from non-arteritic anterior ischemic optic neuropathy","volume":"14","author":"Costello","year":"2004","journal-title":"Eur J Ophthalmol"},{"key":"R34-20260924","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0002-9343(01)00770-7","article-title":"Risk factors for visual loss in giant cell (temporal) arteritis: A prospective study of 174 patients","volume":"111","author":"Liozon","year":"2001","journal-title":"Am J Med"},{"key":"R35-20260924","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1093\/rheumatology\/kez385","article-title":"Sensitivity of temporal artery biopsy in the diagnosis of giant cell arteritis: A systematic literature review and meta-analysis","volume":"59","author":"Rubenstein","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"R36-20260924","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1002\/art.41774","article-title":"2021 American College of Rheumatology\/Vasculitis Foundation guideline for the management of giant cell arteritis and Takayasu arteritis","volume":"73","author":"Maz","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"R37-20260924","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1136\/bjo.86.5.530","article-title":"Effect of prior steroid treatment on temporal artery biopsy findings in giant cell arteritis","volume":"86","author":"Ray-Chaudhuri","year":"2002","journal-title":"Br J Ophthalmol"},{"key":"R38-20260924","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1136\/ard.43.3.416","article-title":"Temporal artery biopsy and corticosteroid treatment","volume":"43","author":"Allison","year":"1984","journal-title":"Ann Rheum Dis"},{"key":"R39-20260924","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1038\/s41433-022-02132-0","article-title":"Role of temporal artery biopsy in a sequential giant cell arteritis fast-track pathway: A 5-year prospective study","volume":"37","author":"Sachdev","year":"2023","journal-title":"Eye (Lond)"},{"key":"R40-20260924","first-page":"OP772","article-title":"Skip areas in temporal arteritis: Myth versus fact","volume":"78","author":"Cohen","year":"1974","journal-title":"Trans Am Acad Ophthalmol Otolaryngol"},{"key":"R41-20260924","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.semarthrit.2018.05.002","article-title":"Arterial lesions in giant cell arteritis: A longitudinal study","volume":"48","author":"Kermani","year":"2019","journal-title":"Semin Arthritis Rheum"},{"key":"R42-20260924","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1136\/ard-2023-224543","article-title":"EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice: 2023 update","volume":"83","author":"Dejaco","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"R43-20260924","doi-asserted-by":"crossref","first-page":"ii22","DOI":"10.1093\/rheumatology\/kex461","article-title":"Ultrasound in the diagnosis and management of giant cell arteritis","volume":"57","author":"Schmidt","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"R44-20260924","doi-asserted-by":"crossref","first-page":"e000598","DOI":"10.1136\/rmdopen-2017-000598","article-title":"Definitions and reliability assessment of elementary ultrasound lesions in giant cell arteritis: A study from the OMERACT large vessel vasculitis ultrasound working group","volume":"4","author":"Chrysidis","year":"2018","journal-title":"RMD Open"},{"key":"R45-20260924","doi-asserted-by":"crossref","first-page":"e003379","DOI":"10.1136\/rmdopen-2023-003379","article-title":"Imaging in diagnosis, monitoring and outcome prediction of large vessel vasculitis: A systematic literature review and meta-analysis informing the 2023 update of the EULAR recommendations","volume":"9","author":"Bosch","year":"2023","journal-title":"RMD Open"},{"key":"R46-20260924","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta20900","article-title":"The role of ultrasound compared to biopsy of temporal arteries in the diagnosis and treatment of giant cell arteritis (TABUL): A diagnostic accuracy and cost-effectiveness study","volume":"20","author":"Luqmani","year":"2016","journal-title":"Health Technol Assess"},{"key":"R47-20260924","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1093\/rheumatology\/kez641","article-title":"False positives in the ultrasound diagnosis of giant cell arteritis: Some diseases can also show the halo sign","volume":"59","author":"Fern\u00e1ndez-Fern\u00e1ndez","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"R48-20260924","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/WNO.0000000000000860","article-title":"Magnetic resonance imaging abnormalities of the optic nerve sheath and intracranial internal carotid artery in giant cell arteritis","volume":"41","author":"Gospe","year":"2021","journal-title":"J Neuroophthalmol"},{"key":"R49-20260924","doi-asserted-by":"crossref","first-page":"3704","DOI":"10.3390\/jcm10163704","article-title":"Imaging tests in the early diagnosis of giant cell arteritis","volume":"10","author":"Prieto-Pe\u00f1a","year":"2021","journal-title":"J Clin Med"},{"key":"R50-20260924","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1136\/annrheumdis-2019-215672","article-title":"2018 update of the EULAR recommendations for the management of large vessel vasculitis","volume":"79","author":"Hellmich","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"R51-20260924","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/BOR.0000000000001029","article-title":"Current management of giant cell arteritis and its complications","volume":"36","author":"Galli","year":"2024","journal-title":"Curr Opin Rheumatol"},{"key":"R52-20260924","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1056\/NEJMra032588","article-title":"Pneumocystis pneumonia","volume":"350","author":"Thomas","year":"2004","journal-title":"N Engl J Med"},{"key":"R53-20260924","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1056\/NEJMoa1613849","article-title":"Trial of tocilizumab in giant-cell arteritis","volume":"377","author":"Stone","year":"2017","journal-title":"N Engl J Med"},{"key":"R54-20260924","doi-asserted-by":"crossref","first-page":"e328","DOI":"10.1016\/S2665-9913(21)00038-2","article-title":"Long-term effect of tocilizumab in patients with giant cell arteritis: Open-label extension phase of the giant cell arteritis actemra (GiACTA) trial","volume":"3","author":"Stone","year":"2021","journal-title":"Lancet Rheumatol"},{"key":"R55-20260924","doi-asserted-by":"crossref","first-page":"106","DOI":"10.7326\/0003-4819-134-2-200101160-00010","article-title":"Combined treatment of giant-cell arteritis with methotrexate and prednisone. A randomized, double-blind, placebo-controlled trial","volume":"134","author":"Jover","year":"2001","journal-title":"Ann Intern Med"},{"key":"R56-20260924","first-page":"495","article-title":"A prospective, double-blind, randomized, placebo controlled trial of methotrexate in the treatment of giant cell arteritis (GCA)","volume":"19","author":"Spiera","year":"2001","journal-title":"Clin Exp Rheumatol"},{"key":"R57-20260924","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/art.10262","article-title":"A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis","volume":"46","author":"Hoffman","year":"2002","journal-title":"Arthritis Rheum"},{"key":"R58-20260924","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1002\/art.22754","article-title":"Adjunctive methotrexate for treatment of giant cell arteritis: An individual patient data meta-analysis","volume":"56","author":"Mahr","year":"2007","journal-title":"Arthritis Rheum"},{"key":"R59-20260924","doi-asserted-by":"crossref","first-page":"101830","DOI":"10.1016\/j.berh.2023.101830","article-title":"Recent advances in the treatment of giant cell arteritis","volume":"37","author":"Springer","year":"2023","journal-title":"Best Pract Res Clin Rheumatol"}],"container-title":["Taiwan Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/tjo.TJO-D-26-00039","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:03:20Z","timestamp":1790255000000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/tjo.TJO-D-26-00039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":59,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/tjo.tjo-d-26-00039","relation":{},"ISSN":["2211-5056","2211-5072"],"issn-type":[{"value":"2211-5056","type":"print"},{"value":"2211-5072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"2026-03-07","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-13","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}